Kintara Therapeutics
The provided source URL (https://kintara.com/) returned 'Not Found'. No company-specific content was available to extract capabilities, technologies, products, people, or contact information.
Industries
biotechnology
health-care
medical
Nr. of Employees
small (1-50)
Kintara Therapeutics
Vancouver, British Columbia, Canada, North America
Patents
Analytical methods for analyzing and determining impurities in dianhydrogalactitol
US-10145824-B2
View DetailsUse of dianhydrogalactitol and analogs and derivatives thereof to treat glioblastoma multiforme
US-9687466-B2
View Details
Analytical methods for analyzing and determining impurities in dianhydrogalactitol
US-10145824-B2
View DetailsUse of dianhydrogalactitol and analogs and derivatives thereof to treat glioblastoma multiforme
US-9687466-B2
View DetailsProducts
REM-001 Therapy
A photodynamic therapy platform for treating serious cutaneous oncology indications, including cutaneous metastatic breast cancer, using a combination of a laser light source, light delivery device, and the drug REM-001.
VAL-083
A chemotherapy agent under investigation for its potential to treat glioblastoma multiforme and ovarian cancer, focusing on cases resistant to current treatments.
REM-001 Therapy
A photodynamic therapy platform for treating serious cutaneous oncology indications, including cutaneous metastatic breast cancer, using a combination of a laser light source, light delivery device, and the drug REM-001.
VAL-083
A chemotherapy agent under investigation for its potential to treat glioblastoma multiforme and ovarian cancer, focusing on cases resistant to current treatments.